Catch up with CHEST 2019 in photos.
Presenters addressed clinical controversies in the session “Clinical Controversies in Lung Nodule Management: Rapid Fire” on Tuesday.
Four experts led a standing-room only session Tuesday morning on the future of identifying and treating sepsis. The session, “Sepsis 2020: What is Down the Pike,” reviewed recent and ongoing research on biomarkers, big data, vitamin C, and fluids.
“The data are pretty compelling that most patients should at least have a trial of antifibrotic therapy,” said Mary E. Strek, MD, FCCP in a Tuesday session.
This year’s Twitter #CHESTChat on Monday evening focused on “Driving Innovation in Pulmonary, Critical Care, and Sleep Medicine.” Here are some highlights from the online conversation.
Presenters addressed these clinical controversies in the session “Clinical Controversies in Lung Nodule Management: Rapid Fire” on Tuesday.
Joel Anthony Nations, MD, MBA, shares four things you should know about the relationship between biological warfare and epidemics before attending the session “Measles, Ebola and Anthrax Oh My! Are You and Your Hospital Ready?” on Wednesday.
“I started working in critical care when I was in my first year of nursing school,” says Janna Landsperger, APRN-BC. “I got a job in the ICU as a care partner and was immediately drawn to critical care.” Read more about this CHEST 2019 attendee.
Presenters addressed these clinical controversies in the session “Clinical Controversies in Lung Nodule Management: Rapid Fire” on Tuesday.
“Through ‘case puzzlers’ programs, these people who don’t have big faculty appointments get a chance to have well-known academic physicians look at how they’ve managed cases,” says Anthony Saleh, MD, FCCP.
Dr. Mark J. Rosen’s passing on July 3, 2019, left an immeasurable void in the CHEST community. On Tuesday, Dr. Rosen’s friend and mentee Lisa Moores, MD, FCCP, will present a session celebrating his work and exploring how he continues to impact the profession.
CHEST® Editor in Chief Peter Mazzone, MD, FCCP, reviewed CHEST’s Screening for Lung Cancer guideline during Monday’s “Clinical Guildelines Update.”